Posturography reflects clinical imbalance in Parkinson's disease
β Scribed by Georg Ebersbach; Maren Gunkel
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 230 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
β¦ Synopsis
Assessment of imbalance in idiopathic Parkinson's disease (IPD) usually relies on semiquantitative ratings. Posturography has been proposed as an objective means to assess imbalance but its relationship to clinical disequilibrium is questionable. In this study static and dynamic posturography was performed in 58 patients with IPD and 29 healthy controls. In patients, posturography was related to performance in established clinical tests (pull-test and tandem gait). Posturography did not differentiate between controls and patients with impaired pull-test (IPDimb, n 5 28). Patients with normal pull-test (IPDstab n 5 30) had lower sway than controls in static (P 5 0.042) and dynamic posturography (P 5 0.001) and also differed from patients with impaired pull-test in static (P 5 0.007) and dynamic (P < 0.001) conditions. In patients with side-steps in tandem gait (n 5 21), sway in static and dynamic posturography was increased. Sway measures did not differentiate between patients with pull-test scores 1 and 2 or one and >1 side step in tandem-gait, respectively. Results of ANOVA showed that variance of static posturography was related to performance in tandem-gait (P < 0.0001) but not to pulltest performance (P 5 0.91). In contrast, dynamic posturography was related to both, tandem-gait (P 5 0.012) and pull-test (P 5 0.03). Posturographic sway is increased in patients with IPD with disturbance of tandem gait and pull-test. Posturographic measures did not distinguish between different degrees of deficits in clinical tests. V
π SIMILAR VOLUMES
## Abstract We prospectively examined associations between perceived imbalance and Parkinson's disease (PD) risk in the Health Professional Followβup Study (HPFS), and Nurses' Health Study (NHS). We included 39,087 men and 82,299 women free of PD at baseline (1990) in the current analyses. We docum
## Abstract The clinical heterogeneity of Parkinson's disease (PD) may point at the existence of subtypes. Because subtypes likely reflect distinct underlying etiologies, their identification may facilitate future genetic and pharmacotherapeutic studies. Aim of this study was to identify subtypes b
## Abstract Despite all recent advances in symptomatic therapy Parkinson's disease (PD) continues to be a relentlessly progressive neurodegenerative disorder. Therefore therapies that will slow or hold disease progression are a major medical unmet need in PD. Clinical measures of disease progressio
## Abstract Over the past decade, major progress has been achieved in the identification of genes associated with Parkinson's disease (PD) and parkinsonism. Five genes have now been shown conclusively to play a role in PD susceptibility. Mutations in three of these genes, __PRKN__, __PINK1,__ and _